Epclusa® 400 mg/100 mg film-coated tablets (batch 15SFPD119): Counterfeit in German packaging offered to wholesaler
2017.05.18
Active substance: sofosbuvir, velpatasvir
The Federal Institute for Drugs and Medical Devices (BfArM) reports that a counterfeit of the company Gilead's medicinal product Epclusa® 400 mg/100 mg film-coated tablets was offered to a wholesaler in Germany.
To the risk information - full text (available in German only)